Advertisement

Hematology and Oncology

Home Hematology and Oncology
Supported by the American Medical Association

AMA Highlights Role of Patient Shame in Opioid Disorders

Webinar on patient shame forms part of Providers' Clinical Support System for Opioid Therapies
The age at which cancer survivors are diagnosed with their disease may help predict their risk of death from cardiac disease

Age at Cancer Diagnosis Key in Determining Later Cardiac Risk

The younger the age at diagnosis, the greater the risk, study suggests
Despite three decades of advancements in treating children with cancer

Long-Term Health Not Improved for Childhood Cancer Survivors

Those treated in 1990s more likely to report pain and poor health as adults, researchers say
Low vitamin D levels may increase the risk of bladder cancer

Bladder Cancer Risk Correlates With Low Serum Vitamin D

Researchers find that bladder epithelial cells activate and respond to vitamin D
Second opinions have little impact on prostate cancer patients' treatment decisions

Second Opinions Seldom Change Prostate Cancer Decisions

Most patients choose treatment they originally planned to follow
Five strategies can be employed by physicians in order to help reduce the risk of lawsuits

Five Strategies Can Reduce Risk of Medical Lawsuits

Strategies include documenting everything, being transparent with patients, showing empathy
Inpatient assessment for inherited thrombophilia is not recommended

No Recommendation for Inpatient Inherited Thrombophilia Testing

Testing is not recommended in most clinical settings; thrombophilia results don't change management
Weight loss following chemically-induced carcinogenesis is not beneficial for colon and liver carcinogenesis in a mouse model that mimics human obesity

Weight Loss May Not Benefit Colon, Liver Cancer

In experimental study, no impact on colon tumorigenesis; may negatively impact liver repair
For patients with locally advanced cervical cancer

Standard of Care Underused for Locally Advanced Cervical Cancer

Despite improved overall survival with standard of care, less than half of patients receive SOC treatment
For women with hormone receptor-positive breast cancer

Adjuvant Endocrine Tx Adherence Disparity Due to Varying Costs

Racial/ethnic disparities in adherence explained by socioeconomic status, medication costs